BeamSite Receives FDA Clearance: World’s 1st Radiation Dose Imaging System is Poised to Impact Radiotherapy

Section 2

Northwell Health Sends Vaccinators to Ecuador

At the request of Ecuador’s Minster of Health, and for the first time since the start of the pandemic, the Northwell Health CGH team traveled outside of the U.S. on June 13 to help get shots in arms relieve overburdened health care workers in the South American country who have been working around the clock in the race to vaccinate their population.

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

January 15, 2021

BeamSite gives clinical teams the power to see what’s happening during the most important time.

Radiation therapy is a powerful tool used by oncologists to provide curative treatments to over a million patients per year in the US, and where one out of every four US citizens will receive it in their lifetime. Trends in radiotherapy treatment are calling for higher doses with fewer treatments, requiring higher demand for superior accuracy and precision in the treatment delivery.

However, for the past 50 years, clinical teams have been working blind – relying on indirect methods to assure the accuracy of treatments that are difficult to use, time-consuming and often imprecise. As a consequence, radiation delivery is actively verified in only about 20% of treatments. BeamSite is the world’s first video system that can directly image radiation therapy as it is delivered to the patient, providing a simple and intuitive means for the clinical team to monitor treatment as it happens, in every treatment, for every patient.

“Radiation therapists are on the front lines when radiation is administered and are best poised to catch any issues that might happen,” says Brian Pogue, co-inventor of the technology and founder of DoseOptics. “BeamSite gives them the ability to see the treatment beam on the patient in real-time. Beyond that, the treatment video is recorded and can be reviewed by the physics or oncology staff anytime.”

Dr. Pogue is quick to add, “We expect it to be an important tool for any radiotherapy center’s quality improvement program.”

DoseOptics’ mission is to improve the safety and accuracy of radiation therapy. It was founded in 2014 based on patented technology developed at Dartmouth’s Thayer School of Engineering in conjunction with the Norris Cotton Cancer Center at Dartmouth Hitchcock Medical Center. Research systems have been successfully deployed at leading academic institutions across the world and resulted in over 50 peer-reviewed publications based on technology.

The latest pilot study was published by radiation oncologist Dr. Lesley A. Jarvis MD Ph.D. and colleagues in the Red Journal of Radiation Oncology (, where they showed significant clinical efficacy. Nearly 10% of patients treated had observations that could be improved for higher quality radiotherapy delivery. They reported, “In this limited cohort, we found opportunities to improve treatment delivery for individual patients… Of specific clinical importance, we show that Cherenkov imaging can detect stray radiation dose to tissues. Currently, there is no practical technique available to monitor contralateral breast dose or dose to other adjacent anatomy on a daily basis.”



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles